Revolution Medicines Reports $407.5M Third-Quarter Loss
Story updates
09:04:05 PM UTC
SquawkNews
Nov 04 (Reuters) - Revolution Medicines Q3 operating income USD -373.149 million.
Related stories
Cathay Pacific Orders 14 Airbus Aircraft
Cathay Pacific ordered 14 Airbus aircraft to expand its fleet.
L impact | EQUITY | Nov 11, 2026, 05:47 AM UTC
IndiGo shares climb 4.3% to near one-year high
IndiGo rose 4.3% to 5,661.20 rupees as crude prices fell.
M impact | EQUITY | Nov 11, 2026, 05:37 AM UTC
KKR Acquires 50% Stakes in Vanguard West and Vanguard East
KKR has acquired a 50% equity stake in each of Vanguard West and Vanguard East, RWE AG says.
M impact | EQUITY | Nov 11, 2026, 05:31 AM UTC
Asian session market picture: S&P 500 +0.66%, Nasdaq 100 +1.4%; USD/JPY +0.02%, WTI +0.28%, 9984 leads volume
Asian session market picture. US index futures: S and P futures is up 0.66 percent, Nasdaq futures is up 1.4 percent, Dow futures is up 0.3 percent and Russell futures is up 0.51 p
M impact | EQUITY | Nov 11, 2026, 05:30 AM UTC
Airbus Wins Firm Order for 14 Additional Aircraft From Cathay Group
Airbus received a firm order for 14 additional aircraft from Cathay Group.
M impact | EQUITY | Nov 11, 2026, 05:26 AM UTC
TSMC Board Approves Up to $1 Billion Investment Plan in Anthropic and OpenAI
Taiwan Semiconductor Manufacturing said its board approved plans to invest up to $1 billion in Anthropic and OpenAI.
M impact | EQUITY | Nov 11, 2026, 05:23 AM UTC